Filing Details

Accession Number:
0001140361-11-013592
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-02 18:05:47
Reporting Period:
2011-02-28
Filing Date:
2011-03-02
Accepted Time:
2011-03-02 18:05:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124105 Targacept Inc TRGT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1295829 S William Caldwell C/O Targacept, Inc.
200 East First Street, Suite 300
Winston-Salem NC 27101
Svp - Drug Discovery And Dev. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-28 15,481 $5.55 23,216 No 4 M Direct
Common Stock Disposition 2011-02-28 15,481 $28.00 7,735 No 4 S Direct
Common Stock Acquisiton 2011-03-01 11,360 $8.51 19,095 No 4 M Direct
Common Stock Disposition 2011-03-01 11,360 $30.00 7,735 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-02-28 15,481 $0.00 15,481 $5.55
Common Stock Stock Option (Right to Buy) Disposition 2011-03-01 11,360 $0.00 11,360 $8.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-08-15 No 4 M Direct
31,472 2017-12-18 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,000 Indirect By Wife
Footnotes
  1. This option vested in installments and became vested and exercisable in full on June 30, 2010.
  2. This option vested (vests) in equal installments on the last day of 16 consecutive calendar quarters beginning with December 31, 2007.